<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
hero-press-releases-1

Newsroom

Press Releases

Our latest announcements

Posts in: machine learning

Media Advisory: Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

Media Advisory: Dr. Heinrich Roder, Biodesix CTO, to speak at precision medicine world conference

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

Findings in the AACR Journal on melanoma patient outcomes after anti PD1 therapy; a serum protein signature predicted survival.

Biodesix’s Diagnostic Cortex™ Platform Used in Three Studies Presented at SITC

The study results indicate that the tests have the potential to offer clinically relevant information that could help physicians selecting immunotherapies for their patients make the best decision